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Ultrasound has been the greatest imaging modality worldwide for many years by equipment pur-
chase value and by number of machines and examinations. It is becoming increasingly the front end
imaging modality; serving often as an extension of the physician’s fingers. We believe that at the
other extreme, high-end systems will continue to compete with all other imaging modalities in
imaging departments to be the method of choice for various applications, particularly where safety
and cost are paramount. Therapeutic ultrasound, in addition to the physiotherapy practiced for many
decades, is just coming into its own as a major tool in the long progression to less invasive
interventional treatment. The physics of medical ultrasound has evolved over many fronts through-
out its history. For this reason, a topical review, rather than a primarily chronological one is
presented. A brief review of medical ultrasound imaging and therapy is presented, with an emphasis
on the contributions of medical physicists, the American Association of Physicists in Medicine
AAPM and its publications, particularly its journal Medical Physics. The AAPM and Medical
Physics have contributed substantially to training of physicists and engineers, medical practitioners,
technologists, and the public. © 2009 American Association of Physicists in Medicine.
DOI: 10.1118/1.2992048I. INTRODUCTION
Ultrasound imaging was the first effective soft tissue imaging
modality used in diagnostic radiology as it provided tomog-
raphic views of the anatomy. After the introduction of ultra-
sound imaging, computed tomography CT and Magnetic
Resonance Imaging MRI were introduced for disease diag-
nosis and management. Although CT and MRI are used ex-
tensively, ultrasound imaging provides unique advantages
over CT and MRI with its ability for real-time imaging, its
low cost, and small size allowing imaging at the patient’s
bedside. Ultrasound imaging and therapy, as a major imaging
and a promising treatment modality, have drawn the attention
of numerous medical physicists and medical physics groups.
A good model for ultrasound in medical physics programs
was provided by the English, perhaps most strongly by Hill
and his group at the Royal Marsden Hospital. The most con-
sistent medical physics programs in research and in training
of medical physicists in ultrasound has been that at the Uni-
versity of Wisconsin under Zagzebski, soon joined by Mad-
sen. The overall Medical Physics program has produced ap-
proximately 220 Ph.D.s, most going into medical physics,
the majority into academic or clinical work. A similarly
strong history occurred later in Toronto, with the ultrasound
part initiated by Hunt and Foster, with a good offshoot at the
University of Western Ontario under a coauthor A.F.. At the
University of Colorado, a coauthor P.C. started an ultra-
sound medical physics effort under Hendee and in associa-
tion with remnants of one of the original medical ultrasound
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the University of Michigan and has continued for 27 years.
Other notable groups in North America were active at Henry
Ford Hospital and Wayne State University, e.g., Ref. 1, Tho-
mas Jefferson University Hospital, e.g., Ref. 2, Temple Uni-
versity, e.g., Ref. 3, UCLA.4 The University of Arizona with
its major early, although not the earliest,5,6 ultrasonic hyper-
thermia effort7 helped spawn several current leading efforts
Harvard,8,9 Washington University,10 and UCSF.11 Several
groups and individual faculty based in physics departments
have also contributed strongly to the field and the supply of
medical physicists. Notable among those are at the Univer-
sities of Mississippi12 and Vermont.13
The journal Medical Physics has contributed through sci-
entific and educational publications; approximately 125 sci-
entific papers on ultrasound have been published in the jour-
nal. The AAPM at its annual meeting has often had
ultrasound scientific sessions and usually had educational
ones. Ultrasound has been featured in several of its summer
schools, e.g., Refs. 14 and 15, and reports.16,17
II. ACOUSTIC WAVE PROPAGATION
Mechanical vibrations of tissues at ultrasonic frequencies
are propagated exceptionally well when the particle vibra-
tions are parallel to the direction of propagation, producing
longitudinal waves. Vibrations transverse to the direction of
propagation, i.e., shear waves, are attenuated very rapidly in
tissues other than bone. That is, tissues that can be sheared
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shear waves in the audible range can be followed by ultra-
sound to produce images of biological tissues. Those basics
of ultrasound propagation are covered well in the many text-
books produced by medical physicists for the various ultra-
sound users,18–21 and in more advanced texts.22–24
III. TISSUE PROPERTIES AND IMAGE ARTIFACTS
Ultrasonic interactions in tissues are at fortuitous levels to
allow sensitive and high-resolution imaging of the tissues.
This serendipity can be thought of in terms trying to design
an ideal nonionizing radiation in which the attenuation in
tissue 0.5 dB cm−1 MHz−1 for ultrasound is not too great,
the speed of propagation is rapid enough to allow rapid im-
aging 1540 m s−1 in soft tissues 6%, the wavelength is
small enough typically 0.1 to 0.8 mm to allow high-
resolution focusing, there is a high-contrast interaction prop-
erty e.g., at tissue interfaces preferably one working in a
reflection mode requiring an unobstructed entrance window
only from one side of the body, and all that at frequencies
allowing inexpensive rf signal detection and processing.25,26
The acoustic intensity changes occur at a macroscopic level,
so ultrasound displays large tissue boundaries, i.e., edge en-
hanced imaging of major tissues. The changes also are at a
subresolution level, so tissue structures also are distinguished
by their backscatter coefficients. Quantitative data on the
most important diagnostic property, the backscatter cross
section or coefficient, is much less well studied and reported,
although there has been some work,27–29 including a great
deal on methods of quantitative imaging of backscatter, to be
discussed under tissue characterization.
The very high soft tissue contrast in ultrasound imaging
comes at a cost, however. The large boundary specular re-
flection is very direction dependent and harder to interpret
for imaging and therapy. The scattering as well as local ab-
sorption of acoustic energy is variable and greater than ideal,
making shadowing and enhancement artifacts quite promi-
nent in the images.30,31 The attenuation artifacts are often
diagnostic, but quite complex32 due to the angle dependence,
particularly of the large boundary scattering component. The
speed of propagation differences far exceed those in ionizing
radiation, leading to refraction and arrival time artifacts.33,34
The typical asymmetric PSF also gives misleading results.35
Coherent imaging in ultrasound allows higher spatial reso-
lution than incoherent, but gives speckle noise and phase
cancellation artifacts.36 The basic properties of tissues as
they relate to artifacts have been rather well studied and ex-
plained in the medical physics literature.37,38 One most im-
portant artifact that has not been well studied is multiple
scattering, which competes with clutter in the point spread
function for filling anechoic structures with low-level ech-
oes. Multiple scattering or reverberation artifacts are distin-
guishable from lateral and elevational clutter by their filling
39in a cyst from the direction of beam entry.
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For a curved surface of an ultrasound transducer, the wave
is launched normal to the surface at every point. For a trans-
ducer element shaped as a spherical section, a nearly ideal
beam is launched toward a focal point, with some important
limits due to diffraction.40,41 Similar spherical and other fo-
cusing can be achieved with shaped radiators and lenses.
With a single element transducer there is only one good focal
point, so high resolution imaging or focused therapy must be
accomplished by physical motion of the transducer, lenses,
or reflectors. These approaches are slow and require rela-
tively frequent maintenance.
With arrays of small transducer elements beams can be
formed in a variety of shapes, described to a reasonable de-
gree by summation of Huygens’s wavelets from the centers
of the elements. For element dimensions 1 wavelength 
in one direction the wave front from a single element falls
off pretty rapidly as a function of angle from the normal to
the element face, so strong focusing or large angle steering
of the beam becomes impossible. Linear, phased, and curved
linear arrays have single elements in the slice thickness di-
rection, with quite weak focusing in that direction focal
length/diameter F number 4. For rapid sector scanning
over large angles, phased arrays are used with element spac-
ings of  /2 and the entire array is employed to transmit
every beam, at least at the greater transmit focal depths.
“Linear” and “curved linear” arrays typically have 1  ele-
ment spacing that allows receive focusing with F number as
small as 1.5, or modest, 20°, beam steering.42,43 Transmit
focusing is not as flexible as receive focusing in beamformed
ultrasonic imaging. Once a transmit focus is chosen, then
only a small range of depths the focal zone has a narrow
beamwidth. To overcome this physical limitation, multiple
transmit focuses are used for each line in the image. Such
focusing has become quite complex.44,45 One can transmit
into a large or medium area and reconstruct well-focused
transmit and receive beams at all depths using multiple trans-
mit pulses46–48 but there are time and signal to noise trade-
offs associated with these synthetic aperture techniques. 2D
arrays are becoming available, initially for cardiac applica-
tions and using many tricks to keep the number of electronic
channels similar to that in current systems, 128 to 256.49,50
Work on construction of 2D array transducers with large
numbers of elements by integrated circuit methods began
some time ago51,52 and is now nearing initial fruition with
capacitative micromachined ultrasonic transducers
CMUTS.53,54
V. SCATTERING FROM TISSUE AND TISSUE
CHARACTERIZATION
Acoustic properties of tissues as measured over many de-
cades were tabulated well by Goss and Dunn.55,56 A quite
complete and remarkably still relevant summary is included
in the excellent book by Duck.57 Most of that data was ac-
quired in vitro, often fixed in formalin, and/or at room tem-
perature. About the time of the Goss and Dunn reviews, ef-
forts at quantitative imaging of ultrasonic interaction
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of “tissue characterization.” It was warned that this title was
too ambitious, suggesting that pathologic states could be
identified unambiguously, that there would be a medical
backlash when artifacts in those measurements and tissue
variability defeated that lofty interpretation of the field.58 In-
deed, exactly that prediction was borne out in the mid 1980s,
after which prominent use of the words “tissue characteriza-
tion” in the rational statement of a grant proposal usually
resulted in rejection of that proposal.
Important properties studied extensively to aid tissue
identification tissue characterization, as well as to aid arti-
fact removal as described above, have included, for example,
ultrasound attenuation coefficient,59–63 speed of propagation,
backscatter coefficient—its directionality and frequency
dependence,62,64–66 impedance,67 nonlinearity parameter,68–70
shear elastic modulus, and shear wave speed,71–73 subresolu-
tion scatterer properties such as surface roughness,74 scat-
terer size, and number density75–78 and combinations thereof,
other statistical properties of backscattered echoes, blood
scattering,79 ultrasound tissue characterization of bone,80 and
cellular imaging and tissue characterization with acoustic
microscopy.81 The effect of temperature was particularly
strong, as was tissue fluid content, which varied strongly
between in vivo and in vitro conditions. Early physics con-
tributions to measures of careful tissue properties interopera-
tively included Refs. 82 and 83. Considerable effort was and
continues to be directed toward quantitative imaging in vivo.
VI. IMAGING SYSTEMS
The last two decades have witnessed significant changes
in ultrasound imaging systems. The first digital scan con-
verter was developed by medical physicist Goldstein under
NSF Grant GJ-41682. With the advances in computer tech-
nology and miniaturization, ultrasound systems have incor-
porated higher-end features in lower cost systems and sys-
tems have become smaller. With these advances, portable
ultrasound systems with full features are now available. Ex-
amples of portable systems are manufactured by: Terason,
which uses a full 128-channel system and consists of a lap-
top computer, a transducer, and a small processor box; and
by Sonosite, which makes use of custom designed
application-specific integrated circuit ASICS.
A typical ultrasound system is generally composed of ma-
jor components, which are described in the following sec-
tions. Ultrasound systems are explained in standard medical
physics texts.19,20 Most ultrasound textbooks generally are
also for residents and technologists,84 and some are for sci-
entists and engineers.22–24
Each ultrasound system has a selection of ultrasound
transducers typically designed for use at different frequen-
cies and for specific applications, such as endo-cavity, vas-
cular, abdominal, small parts, etc. imaging. Modern trans-
ducers are composed of piezoelectric linear or multielement
phased arrays capable of producing images in real time.
Most arrays are one-dimensional, typically with 128 or more
elements. Since one-dimensional arrays have fixed focusing
Medical Physics, Vol. 36, No. 2, February 2009in the direction perpendicular to the array elevation, some
systems have additional transducer elements generating what
is generally labeled as 1.5D arrays, allowing more flexibility
in focusing in the elevational direction. Two-dimensional ar-
rays are also now available in high-end systems allowing not
only focusing in the elevation direction, but also real-time
3D imaging i.e., 4D imaging.85
Typical system user interfaces makes use of a computer
keyboard used to enter patient information, and custom but-
tons, knobs, and sliders used to control the operation of the
system. Some systems make use of touch screens, obviating
the need for a computer keyboard. In addition to input capa-
bility, the systems also provide means for connecting to a
local area network for archiving of images and transmitting
images to remote diagnostic stations.
The front-end electronics subsystem provides beamform-
ing and signal-processing capability of the ultrasound ma-
chine. The transmit beamforming components organizes the
signals to be sent to the transducer elements with proper
timing. Echo signals received by the transducer are sent to an
analog-to-digital converter and then organized by the beam-
former to prepare the signals for generation of the ultrasound
image. Thus, this subsystem includes signal-processing capa-
bility such as filtering and generation of signals for Doppler
imaging.
The back-end electronics subsection receives the rf sig-
nals from the beamformer and generates the ultrasound im-
age. This involves organizing the signals from the data lines
through a scan converter into the proper raster scan format
suitable for the computer or video monitor. Thus, this sub-
system incorporates multiple functions, such as color and
gray-scale mapping and compression.
The subsystems described above are controlled by a con-
troller, which is composed of a computer or multiple micro-
processors in modern systems. This subsystem interacts with
the user interface and sets up the proper transmit and receive
beamformer settings suitable for the selected transducer and
the desired image settings.
Multimodality systems involving ultrasound are increas-
ing in number and importance. They include thermoacoustic
imaging,86,87 of which photoacoustic imaging is a promising,
most active area of research.88–90 Ultrasound has been at-
tached to CT scanners and surgical equipment for real-time
guidance of interventions planned with CT. Ultrasound has
been used with microwave, electrical, and diffuse optical im-
aging to guide reconstruction of those less deterministic im-
aging methods.91,92 Combined ultrasound and
mammography/tomosynthesis systems are described under
breast imaging.
VII. DOPPLER AND OTHER FLOW IMAGING
MODES
The Doppler effect is used extensively in ultrasound im-
aging and is a key capability of most ultrasound machines.
The physical principles and use of the Doppler effect for
investigating blood flow are covered in detail in many books
and review articles. The technique is generally well under-
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The technique has progressed from simple continuous wave
cw Doppler, which provided a sensitive method to measure
blood velocity component but with the limitation of range
ambiguity, to pulse wave PW Doppler, which overcame the
range ambiguity limitation with range gating, to color flow
imaging CFI techniques.93,94
Color flow imaging CFI was developed in the 1980s and
provided a real-time blood velocity component and direc-
tion displayed in color superimposed on the gray-scale
B-mode ultrasound image. This development represented a
major advance in medical ultrasound and greatly extended its
use in vascular and cardiac imaging. Typically, red is as-
signed to flow toward the transducer and blue away from it,
with the color intensity increasing proportionally to the ve-
locity. Since the velocity and direction must be calculated in
multiple locations to cover a region of interest, the CFI im-
age frame rate suffers. Thus, to increase the frame rate to
observe fast events, the region-of-interest is reduced.
In the 1990s a variation of CFI was developed and was
initially studied by a medical physics group and collaborat-
ing radiologists.95 This development is usually called power
Doppler imaging or ultrasound angiography. In this tech-
nique, only the Doppler signal power or intensity is dis-
played superimposed on the gray-scale B-mode image, with
no velocity direction.96 Since this technique is dependent on
the integrated reflected power generated by moving red
blood cells, it is more sensitive to flow than CFI and can
produce a useful image of blood flow even close to 90° to the
transmitted beam. The increased sensitivity of this technique
allows imaging of small vessels and blood flow in tumors.
3D techniques have also been applied to both CFI and
power Doppler imaging. One approach made use of a linear
mechanical scanning mechanism to translate the transducer
as Doppler color flow or power Doppler images was ac-
quired by a computer and reconstructed into a 3D image.
This 3D technique has been implemented in many vascular
B-mode and Doppler imaging applications, particularly for
carotid arteries and tumor vascularization. North American
medical physics groups and the journal have been particu-
larly active in this field.95,97,98 Heart, and obstetrical applica-
tions have also been explored intensively.37,99 Figure 1 shows
several examples of linearly scanned 3D images made with a
mechanical scanning mechanism.
Since the Doppler effect provides information on the
component of the blood velocity relative to the ultrasound
beam, the actual velocity vector information of the blood
flow is not available. Thus, investigators have pursued the
development of techniques that provide the true blood veloc-
ity and the direction of its vector. These techniques include
velocity estimation using correlation,100 wideband maximum
likelihood,101 and spatially separated Doppler transducers.102
VIII. NONLINEAR ACOUSTICS AND IMAGING
Linear acoustic propagation in a medium with respect to
ultrasound would result if the shape and amplitude of the
signal at any point in the medium were proportional to the
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erty with respect to ultrasound propagation, resulting in the
shape and amplitude of the acoustic signal changing as it
propagates into the tissue. Specifically, ultrasound propaga-
tion in nonlinear tissue results in pulse and beam distortion,
harmonic generation, and saturation of acoustic pressure.
This is caused by the fact that, as a sinusoidal signal of a
single frequency is generated and transmitted into a non-
linear medium, the signal will distort as it propagates be-
cause the compression phase velocity of the signal is greater
than the velocity of the rarefaction phase. This effect will
result in distortion of the wave as it propagates so that a
“sawtooth” or “N”-shaped wave is generated, which has fre-
quencies at harmonic multiples of the fundamental fre-
quency. Since tissue attenuation increases with frequency,
the higher harmonics will be attenuated, leaving an attenu-
ated low-frequency signal at greater depths. Investigation of
generation of harmonics in water by ultrasound imaging sys-
tems began in the 1970s and 1980s.103–105 Use of nonlinear
acoustics in medical imaging systems accelerated in the
1990s with primarily two applications: tissue harmonics and
ultrasound contrast agents.
Tissue harmonic imaging was investigated in the 1990s
by several groups.106,107 and was commonly available in
clinical ultrasound systems by the late 1990s. Two competing
effects characterize ultrasound propagation in nonlinear me-
dia such as tissue. Increasing harmonics with propagation
distance leads to increased absorption. The latter reduces
pressure amplitude and harmonic generation. Since tissue
FIG. 1. Three-dimensional ultrasound images obtained using a mechanical
scanning mechanism and shown using a cube-view approach. a B-mode
image of a kidney; b power Doppler image of a kidney; c Doppler image
of the carotid arteries, showing reverse flow in the carotid sinus.heating is a consequence of absorption, nonlinear effects en-
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have occurred at the fundamental propagation
frequency.108,109
Tissue harmonic imaging is typically implemented by fil-
tering out the fundamental ultrasound frequency of the re-
ceived beam. Second harmonic images have been shown to
often improve contrast and resolution as compared to images
generated by the fundamental frequency. These advantages
result from multiple improvements, such as narrower beam-
width, reduced sidelobes, reduced reverberations and mul-
tiple scattering, reduced grating lobes, and increased dy-
namic range.107,110 This is primarily due to the fact that these
unwanted signals are mainly incoherent and are small in am-
plitude. Thus, they do not generate harmonics and can be
filtered out in the second harmonic image.111 In addition,
since harmonics are proportional to the square of the funda-
mental pressure, increasing the acoustic input pressure will
generate a disproportionate increase in the second harmonic,
compared to the situation in which the medium is linear and
no harmonics are generated Fig. 2.
Elasticity and shear wave imaging is a natural application
for ultrasound imaging, given the latter’s coherence and abil-
ity to track small motions, particularly in the direction of
ultrasound wave travel. Once again, efforts at quantitative
imaging, e.g., nonlinearity parameter and tissue harmonic
FIG. 2. Nonlinear propagation: a measured pressure waveform and spec-
trum of a 1.67 MHz sound pulse transmitted 10 cm through beef; b wave-
form and spectrum following transmission through water; and c measured
focal beam profiles of the fundamental solid lines and nonlinear second
harmonic beams dashed lines. Since harmonic amplitudes are proportional
to the square of the fundamental pressure, the wave passing through the
relatively unattenuating water generates a disproportionate increase in the
second harmonic, compared to that passing through attenuating muscle. The
harmonic beam has a narrower main lobe and weaker sidelobes than the
fundamental beam. From Burns, Ref. 111.imaging, perfusion and power mode Doppler imaging, back-
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paid off most directly in converting the measured
quantity112,113 into an imaging one,114,115 usually nonquanti-
tatively. Tissue firmness to the touch has always been a ma-
jor diagnostic tool. The modulus of elasticity or simple
durometer testing has shown the information to be there with
very high contrast. Ultrasound and MR imaging with dy-
namic and quasistatic115–118 displacements have followed
with good success, although plagued by many artifacts due
to the simplified assumptions and that the imaging of elas-
ticity instead of strain must contend with noise of an addi-
tional derivative.118 The shear elastic modulus is responsible
for perceived hardness and can be approached by imaging
shear wave propagation with ultrasound or MRI, where the
shear waves can be generated at locations of interest by ra-
diation force at the focus of an ultrasound beam.73,119 Very
localized displacements can be produced and elasticity imag-
ing accomplished in the vicinity of laser and acoustically
produced, acoustically driven microbubbles.120,121 The litera-
ture on techniques and applications is too extensive to cover
here, but the contributions of the Wisconsin medical physics
group are notable.122,123
Ultrasound contrast agents: Developments and applica-
tions of ultrasound contrast agents have been intensely inves-
tigated throughout the world, but less so in the USA, where
their approved range of applications is extremely limited.
Quite restrictive contraindications and monitoring require-
ments were placed on the use of ultrasound contrast by the
FDA, but those were relaxed substantially quite recently.124
Hopefully the range of approved applications will also be
broadened. Most ultrasound contrast agents are encapsulated
gas-filled bubbles 1–10 m that are intravenously in-
jected. Here, we summarize the nonlinear effects related to
microbubbles, but for information on the physics and imag-
ing applications related to gas bubbles, the reader is referred
to recent reviews.125,126 The strong scattering of resonant
bubbles was recognized early and medical physicists contrib-
uted in their acoustic characterization.127,128 In the presence
of an acoustic field, microbubbles act as highly nonlinear
resonators. For acoustic fields with a low pressure, the
bubbles undergo forced vibrations and can keep up with the
fluctuating pressure field—linear resonance. However, as the
pressure is increased, they can expand with the rarefaction
phase, but cannot contract without limit due to the encapsu-
lated gas. Thus, as determined by a leading ultrasound
physicist,129 the bubbles’ pressure expansion and contraction
response is asymmetric, resulting in harmonics and other be-
havior of highly nonlinear scatterers of ultrasound.130 In har-
monic imaging with contrast agents, the signals at fundamen-
tal frequency primarily generated from tissue are suppressed,
allowing imaging of the scattered signals at the second har-
monic, as studied extensively by Burns,131,132 an import from
English medical physics training. Since the passband of the
transmit signals at the fundamental frequency and the pass-
band of the receive signals at the second harmonic may over-
lap, the large linear signal from tissue may mask the har-
monic signal from the small quantity of contrast agent. Thus,
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reducing axial resolution. The trade-off between contrast and
resolution in contrast imaging leads to the use of increased
transmit intensities, in which micro-bubble destruction can
occur, resulting in reducing imaging frame rate to maintain
detection sensitivity.133 Techniques to overcome these limi-
tations are being investigated and innovations involving
power-dependent and pulse-inversion techniques are being
developed.134 3D quantitative imaging of mean vascular tran-
sit time and perfusion with ultrasound contrast agents has
been time consuming.135 The step to 3D contrast enhanced
physiologic imaging is critical to realize the clinical poten-
tial, and some progress has been made.136
IX. SPECIALIZED SYSTEMS AND APPLICATIONS
DEVELOPMENT
IX.A. Breast imaging
Breast imaging with ultrasound is a special case because
of the emphasis it has received and the opportunities for
innovation. Since the early days of ultrasound imaging,
breast cancer detection and diagnosis has been a target ap-
plication and one emphasized by medical physics
researchers.137–140 Breast motion during the mechanical scan-
ning as well as lower ultrasound frequencies, fixed focus and
mechanical instability of the compound imaging articulated
arm
141 produced much lower resolution than was achieved
subsequently. It was rather clear that ultrasonic discrimina-
tion of cysts was quite complementary to information from
mammography, a fact that continues to be confirmed with
more advanced systems and techniques.142,143
Pushing a relatively small, 1D linear array close to the
lesion without concern for displaying the entire breast en-
abled the use of higher frequencies. That, along with dy-
namic electronic focusing on reception and multiple transmit
foci with larger apertures, allowed higher resolution and sen-
sitivity. Such arrays are still the current state of clinical prac-
tice. Color flow imaging and other Doppler studies have
been performed extensively by medical physicists and others
as a possible discriminator of breast cancer.144,145 Breast can-
cers are, in general, more vascular, with somewhat distinc-
tive patterns, and their vascularity can contribute to the di-
agnosis. However, it is still controversial as to whether the
improvement is worth the added time of performing a Dop-
pler study.
Automated and other 3D imaging: 3D imaging of the
breast offers substantial potential advantages because of the
more consistent coverage and better statistical sampling of
features such as border characteristics, shape, and vascular-
ity. Approaches have included major commercial efforts to
establish ultrasonic breast cancer screening in the U.S. with
water path scanners in the early 1980s. These efforts failed to
convince the medical community. Free-hand 3D scanning al-
lowed higher frequencies with less aberration and is often
used now without position encoding in the slice thickness
elevational direction to record entire regions of interest.
With encoding of the elevational motion, the potential of
whole breast imaging is increased. Reproducibility of posi-
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supine scanning, where the breast tissues are spread out by
gravity to maximize imaging depth and therefore greatest
usable frequency and control of artifacts. Ultrasound imag-
ing in the compressed mammographic geometry allows bet-
ter correlation of lesions and other structures between the
ultrasound results and those of mammography.146–148 This
geometry probably can provide more complete coverage of
breast tissues than imaging with water paths in coronal
planes breast axial planes, as is done for ultrasonic CT and
dedicated breast x-ray CT, but worse coverage than free-
hand scanning in the supine position.
Ultrasonic CT UCT allows detection of transmitted and
forward scattered ultrasound as well as backscatter. UCT was
studied extensively in the late 1970s and early
1980s,138,149–159 but was caught in the decision of the U.S.
medical community that ultrasound breast cancer screening
and quantitative imaging tissue characterization were not
productive or were premature. This setback is being over-
come only in the last few years, with a resurgence based on
new technologies and steady science. The large 360° aper-
ture available in scanning the dependent breast in horizontal
planes allowed many advanced imaging schemes based on
corrections for, or imaging of, diffraction and variable propa-
gation speed.137,149,152,153,159–161 Much of the most advanced
work has been done with the assumption of cylindrical ge-
ometry, using full ring array transducers,162 now with reason-
able focusing in the slice thickness direction. The latest ver-
sions of these approaches are producing rather good results
for attenuation, speed of sound, backscatter, and other inter-
action images, but there are substantial artifacts, particularly
in the attenuation images. An alternative approach is a
simple transmission array and a 2D receiving array that ro-
tates fully Techniscan Med. Syst., Salt Lake City, UT.163
There have been quite a few efforts to develop and test
systems of automated 3D US in a mammographic
geometry164–167 in both a combined system and in separate
systems. One such system, while successful in finding all the
cancers, missed smaller benign masses. The study was
stopped due to the breast slipping out of compression due to
the slippery coupling gel and due to limited visibility of le-
sions near the nipple and chest wall.168 One stand-alone de-
vice approached commercialization in the mammographic
geometry, but was changed to the simpler supine scanning
geometry.169 Others claim to have found ways to ameliorate
compression and coupling problems and achieve the impor-
tant goal of direct spatial colocalization of structures in
mammographic and DBT images with automated ultrasound
images.170
IX.B. Brain imaging
While transmission of focused ultrasound through the
skull poses significant problems, trans-skull ultrasonic propa-
gation for diagnosis and therapy has been investigated for
several decades. The use of trans-skull ultrasonic imaging
has primarily been directed at transcranial Doppler to detect
blood flow in some cerebral arteries or lack of blood flow
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few years, the use of transcranial ultrasound for therapeutic
application has attracted significant interest based on and
leading to a number of novel applications, such as acoustic
tomography,152,171,172 targeted drug delivery and blood-brain
barrier disruption,173 cerebral arteries blood flow,174 thermal
tumor treatment,175 and use of transcranial ultrasound in is-
chemic stroke therapy,176 all discussed subsequently.
Therapeutic applications rely on the use of focused ultra-
sound to create well-delineated regions of energy deposition
via high-frequency mechanical oscillations of tissue. Key to
therapy applications is the ability to localize the delivery of
energy to a well-delineated region. However, the skull is not
a simple medium with a single thickness and speed of sound.
Rather, the skull varies in thickness, density, acoustic absorp-
tion, and speed of sound, resulting in deformation of the path
of the longitudinal transmitted sound. These properties create
difficulties in focusing the acoustic field and delivering the
planned energy to the desired region. In addition, the high
acoustic absorption of the skull limits the amount of energy
that can be delivered.
Investigators have attempted to solve the problems asso-
ciated with propagation of longitudinal acoustic waves
through the skull by correcting the phase and amplitude of
the transmitted sound. Some approaches have used multiple
acoustic sources. By correcting the relative phase and ampli-
tude generated by each source, it is possible to produce a
well-delineated pressure field inside the brain.177,178 This can
be accomplished by obtaining detailed information on the
morphology of the skull region used for transmission of the
acoustic energy. Using geometric and compositional infor-
mation, a sound propagation model can be used to plan the
phase and amplitude correction needed to produce the de-
sired focused field in the brain.179 The required information
can be obtained using MR imaging178 or CT. With 2D arrays
offering independently addressable elements on transmit and
receive,180,181 or possibly with a chaotic cavity,182 aberration
correction will be obtainable with ultrasound.
Longitudinal acoustic trans-skull transmission has been
used for a few decades with various degrees of success.
More recently, shear wave transmission has been explored in
an attempt to circumvent some of the problems facing lon-
gitudinal transmission. When an ultrasonic wave traveling in
water arrives at the skull interface, a longitudinal reflected
wave, a longitudinal transmitted wave, and a shear transmit-
ted wave are generated. At an incident angle of 25° or larger,
only a shear wave is transmitted. Since the speed of sound of
shear waves in skull is close to the speed of sound in water
and brain tissue, distortions of this wave are less severe than
with longitudinal waves. Although distortions due to skull
density and variation of thickness are less severe with shear
wave transmission through the skull, skull attenuation of
shear waves is greater than longitudinal wave attenuation.
Nevertheless, applications making use of shear wave trans-
mission that do not require delivery of high energy levels
show promise and are being explored by a number of
183investigators. These applications include brain-blood-
Medical Physics, Vol. 36, No. 2, February 2009barrier disruption, mentioned above,184,185 tissue destruction
using cavitation,186 and heating using bubbles187 Fig. 3.
IX.C. Small animal and early stage molecular imaging
Imaging of small animals in vivo requires resolution better
than 200 m, which yields anatomical detail comparable to
clinical imaging of humans.188 Thus, the use of ultrasound in
imaging of small animals requires that the systems use center
frequencies higher than 20 MHz. However, the use of high
frequency imaging needed to obtain high resolution limits
the penetration depth due to increased attenuation with fre-
quency, and limits the field-of-view compared to high-
resolution micro-CT or micro-MR. In addition, the usual
limitation related to the inability to image bony and air-filled
anatomy limits applications to imaging of soft tissues. How-
ever, the flexibility, real-time imaging capability, and low
cost of high-frequency ultrasound imaging systems have
stimulated developments and many applications in their use
for preclinical investigations making use of small animal re-
search models. These have been stimulated by the release of
a commercial microultrasound imaging system VisualSonics
FIG. 3. a Experimental apparatus used to generate the results in b, which
shows the MRI-based temperature maps left and contrast-enhanced T1-
weighted images right of two sonications in two rabbit brains with A and
without B preinjection of Optison®. Isotherms drawn at 3 and 4 °C are
superimposed on the T1-weighted images in the insets. With Optison®, the
length of the focal zone was reduced, and the heating was centered at the
focal plane dotted line in the temperature images. The images were ac-
quired parallel to the direction of the ultrasound beam. Note that in both
cases a second location inferior to the first was also sonicated. In these
images, the ultrasound beam propagated in a direction from left to right. A:
1.2 W /10 s, 2.8 MPa, pulsed; B: 3n W /10 s, 4.4 MPa, CW. From
Hynynen, Ref. 185.Inc., Toronto, Canada.
418 P. L. Carson and A. Fenster: Evolution of medical ultrasound physics 418Applications in cancer research were among the first iden-
tified for microultrasound,189 and the use of Doppler imaging
at high frequencies allowed investigations of tumor microcir-
culation mapping.190,191 Analysis of the radio-frequency
spectral parameters allowed investigations of apoptosis, as
well as investigations of different tumor microstructure
characteristics.192,193
While 2D B-mode microultrasound imaging provided a
valuable tool in cancer research, 3D imaging capability was
shown to offer important advantages.194 Thus, investigators
have begun to extend the use of micro-ultrasound imaging to
3D by mounting the transducer on a mechanical motorized
mover and collecting parallel 2D images separated by a com-
puter controlled spacing.195–197 Typically, the images were
separated by 50 m, requiring 200 images to cover 5 mm.
This approach allowed accurate measurements of irregular
shaped regions and accurate estimates of tumor volume re-
quired in monitoring tumor progression and regression.195–197
Three-dimensional imaging also allowed viewing of
anatomy in any orientation including views not possible us-
ing 2D imaging. This capability improved the ability to vali-
date the developments of biomarkers of disease in preclinical
studies of cancer and atherosclerosis,198–200 and allowed de-
tailed investigations into the neoangiogenesis process in ani-
mal tumor models Fig. 4.201 Microvascular elasticity imag-
ing also is promising.202
Microultrasound also provides an important tool for the
study of embryo development in the mouse. The use of
40–50 MHz microultrasound imaging has provided suffi-
cient resolution to examine the development of the heart in a
mouse from early embryonic to later neonatal stages.203,204 In
addition, real-time imaging at high resolution with high-
frequency ultrasound has also allowed investigations into
placental circulation in mice205 and analysis of lethal and
nonlethal dilated cardiomyopathy in mutant mice during the
first week after birth.206
During the last decade, important advances have ad-
vanced the use of microbubble contrast agents, which allows
lesion perfusion analysis with a sensitivity comparable to CT
and MR. For a current summary of this field, the reader is
referred to a review by Ferrara et al.125 The use of mi-
crobubble contrast agents in preclinical studies is expanding
rapidly, particularly with the development of techniques used
to conjugate bubbles to ligands that cause them to adhere to
receptors such as VEGFR, allowing investigations of angio-
genesis and inflammation.207,208
X. PERFORMANCE EVALUATION
Ultrasound system quality control and performance evalu-
ation has been studied and developed rather extensively, al-
though the demand for routine services has not been as great
as with more regulated imaging modalities. The first standard
for testing of ultrasound imaging systems was the AIUM
100 mm Test Object.209 Compared with a wire-holding
frame in an open water bucket, this device offered in one of
its forms the convenience of an enclosed water tank for off
the shelf use with ease of alignment of the image plane with
Medical Physics, Vol. 36, No. 2, February 2009internal wires. The Southwest Regional Center for Radio-
logical Physics, Hendee, P.I., funded by NCI and adminis-
tered through the AAPM, provided the first national program
for education in ultrasound system QC, performance evalua-
tion, and safety. Wires in water were replaced by tissue-
mimicking phantoms developed in the medical physics de-
partment at the University of Wisconsin210 and their
approach has dominated the market for several decades. Wa-
ter loss over time is a problem but alternatives have similar
problems, limited applications, or inconvenience.211,212 Nu-
merous standards and guides for ultrasound QC and higher-
level performance evaluation have been produced nationally
and internationally by organizations with strong participation
by medical physicists, e.g., Refs. 16, 17, and 213.
XI. ULTRASOUND-INDUCED BIOEFFECTS
Because of the high acoustic pressures involved and pre-
vious experience with other medical imaging and therapeutic
radiations, patient safety and the potential for therapeutic use
has been an important issue from the beginning of medical
ultrasound research. The research and guidelines for safe use
are summarized regularly.214–217 One of the largest uncertain-
ties is probably estimation of the exposure level in situ, be-
cause of the large and highly variable attenuation of ultra-
sound. This uncertainty has been addressed by simple218 and
more complex models219 and by difficult measurements in
humans in vivo.220 These guidelines have been directed to-
ward imaging in the typical diagnostic range of 1–15 MHz,
but higher frequencies do not raise special concerns as long
as thermal effects are considered appropriately. Thermal ef-
fects on the embryo/fetus of diagnostic ultrasound have been
a topic of strong interest, but training and real-time output
display requirements218 persuaded the FDA to raise general
purpose ultrasound output guidelines for 510k approval to
the higher cardiovascular limits. This move probably has re-
sulted in better and more versatile ultrasound systems, but
there are not large safety margins. Apparently negligible
damage can be done to microvasculature by ultrasound at the
lung surface at the highest outputs,221 as can extremely focal
vascular leakage from bubble oscillations in high-amplitude
ultrasound fields.222 The only known location of a potentially
substantial effect is in the kidney, where the high blood pres-
sure gradients can cause enough hemorrhage for loss of the
nephron.223
XII. ULTRASONIC EXPOSIMETRY, ACOUSTIC
MEASUREMENTS, AND SAFETY STANDARDS
The study of methods for measuring exposure levels, and
their relationship to possible biological effects, accelerated as
ultrasound became the dominant method of imaging the fetus
and was used even in normal pregnancies. Resulting expo-
simetry methods are reviewed regularly.224,225 Ultrasound ex-
posures from commercial imaging systems have been re-
ported rather extensively.103,226 Requirements for reporting
relevant output of commercial systems227,228 kept up with or
exceeded those for x-ray imaging and the requirement for
real time, on-screen reporting of estimated biophysically rel-
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field.218,229
XIII. ULTRASONIC THERAPY
The topic of ultrasonic therapy and the role of medical
physics therein is too large to cover adequately in this re-
view, but some pointers to the literature will be given, in-
cluding recent reviews.230 The most effort has been on hy-
perthermia for cancer treatment. There is a therapeutic
FIG. 4. Power Doppler ultrasound images of vasculature in a GEM-prostate
in the first row, a three-dimensional power Doppler image, a three-dimensio
Doppler image, the matching two-dimensional plane from the three-dimensi
micro-CT images of a 7.1 mm3 tumor. Second and third rows, equivalent
Arrows, sites used for registration of corresponding vessels. Bars, 1 mm.
dimensional power Doppler and micro-CT images shown in A. The powe
tively are shown on separate graphs. Adapted from Xu et al. Ref. 201.advantage for thermal treatment of tumors with high meta-
Medical Physics, Vol. 36, No. 2, February 2009bolic rates and often poor thermal protective mechanisms.
However, it is hard to maintain the temperature in a narrow
window for an extended period of time, particularly for large
treatment volumes. More effort has been directed in recent
years to thermal and mechanical cavitational ablation. A
method of very high-amplitude ablation, histotripsy, is par-
ticularly promising. Here, clouds of cavitation bubbles are
initiated and carefully controlled with relatively low heating
Hyperthermia and tissue ablation are referred to in the
r model are verified by Microfil-enhanced micro-CT. A, from left to right
icro-CT image, a two-dimensional plane from the three-dimensional power
icro-CT image, and an overlay of the two-dimensional power Doppler and
nces of images from a 130 mm3 tumor and 370 mm3 tumor, respectively.
ar graphs of internal and peripheral vascularity estimated from the three-





r Dopterm high-intensity focused ultrasound HIFU. This acro-
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are emitted from a high-powered transducer that can target a
tissue volume inside the body. The energy deposition causes
a sharp temperature increase within the focal volume, result-
ing in tissue coagulation, necrosis, and the elevation of lo-
calized tissue stiffness. Two principal mechanisms, tissue
heating and acoustic cavitation, are responsible for HIFU-
induced tissue damage. Each mechanism enhances the other.
HIFU systems commonly operate in a frequency range of
0.5–5 MHz, generating focal high-level intensities in a
range of 1000–10 000 W /cm2 that cause irreversible cell
destruction and protein denaturing in seconds.
HIFU treatment is noninvasive and nonionizing, which
means it can be repeated as desired, having no long-term
cumulative effects when performed accurately. It increases
tissue temperature in the focal area up to 60 °C for tempera-
tures to as high as 100 °C in seconds, which is sufficient to
induce thermal coagulation while minimizing blood perfu-
sion effects. However, potential limitations to the current
clinical application of HIFU still exist, such as the long treat-
ment time with large tumor, deeply located tumors. Due to
the total power attenuation through the intervening tissue,
there exists an upper bound of treatable tumor volume at a
given depth. The relationship between the therapeutic vol-
ume and tumor depth is shown in Fig. 5.231 In some cases,
patients complain about local pain after HIFU therapy, which
may be caused by normal tissue overheating, although this is
not terribly common. Periosteal pain can be severe and is a
challenge because of the rapid heat deposition of ultrasound
in bone.232 The diaphragm, lung, bowel, and other gas-
bearing tissues are likely targets for cavitational and thermal
damage.219
The initial applications of HIFU on biological tissues
were proposed by Lynn et al.233 in 1942. Later, Burov234
suggested using HIFU to treat malignant tumors. The bioef-
FIG. 5. Maximum treatment volume size allowed by heating of overlying
tissues as a function of tumor depth, various body aperture sizes, given
typical tissue properties. Adapted from Ref. 231.fects and specific properties of focused ultrasound on tissues
Medical Physics, Vol. 36, No. 2, February 2009were investigated in further studies.5,56 As mentioned earlier,
the group at the University of Arizona7,235 trained many
people in therapeutic ultrasound who have established and
enhanced programs throughout the country, including several
in medical physics programs. In the last two decades, the
potential of HIFU for clinical use has been enhanced greatly
by combining HIFU treatment with MRI guidance.236 Image
guidance by ultrasound or other modalities,237,238 allows rea-
sonably accurate HIFU dose delivery to the target tissue with
minimal damage to the overlying and surrounding normal
tissue. Imaging modalities also play an important role in
treatment follow-up by means of the treatment efficacy, early
recurrences, and therapy-induced complications.
Histotripsy offers the potential of tissue ablation without
substantial heating of overlying tissues, as the violent activ-
ity of a microbubble cloud in an intense ultrasound beam
liquefies the tissue to the subcellular level.239 Extremely pre-
cise surgery can be performed transcutaneously with this
technique in accessible locations. The treatment can be
monitored easily with conventional ultrasound imaging.240
However, treating large volumes at present still requires sub-
stantial time to avoid unacceptable heating of overlying tis-
sues.
Drug delivery,173 clot disruption,241 accelerated
healing,242 and hemostasis of vascular injuries243 and
incisions244 are among many advanced therapeutic applica-
tions of ultrasound.
XIV. THERAPY TREATMENT PLANNING AND
GUIDANCE
Development of ultrasound for treatment planning was
ongoing some time ago.245 Ultrasound has been studied and
developed and used qualitatively and quantitatively to evalu-
ate response to chemotherapy246 and various experimental
drugs.247 Prostate therapy has been a leading application of
ultrasound for treatment planning because of its accessibility
for ultrasound imaging and the utility of nearly real-time
feedback. This application is treated in detail as an example.
XIV.A. Prostate therapy treatment, planning, and
guidance
The most common treatment regimens for clinically local-
ized prostate cancer are watchful waiting, radical prostatec-
tomy, external beam radiation, and brachytherapy. While
watchful waiting is appropriate for some, the majority of
men diagnosed with early stage cancer will request or need
treatment. While very effective, radical prostatectomy does
entail some significant morbidity incontinence and impo-
tence. Although various prostate treatment techniques have
been developed and investigated over the past decade, e.g.,
brachytherapy, cryosurgery, hyperthermia, interstitial laser
photocoagulation ILP, and photodynamic therapy PDT,
external beam radiotherapy and brachytherapy are still com-
mon. These techniques have benefited greatly from advances
in ultrasound imaging technology and techniques.
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prostate radiotherapy
Advances in external beam radiotherapy techniques have
generally resulted in improved precision and accuracy in the
delivery of radiotherapy, allowing better control of the dose
distribution within the target and sparing normal tissues.
These techniques require better methods to delineate the
prostate boundaries as well as improved methods to monitor
prostate motion.248 Various imaging techniques have been
applied to high-precision prostate radiotherapy, including ul-
trasound imaging.
Transabdominal ultrasound imaging has had an important
impact in daily prostate localization before treatment,249 and
several ultrasound-based systems have been developed for
image-guided radiotherapy. In these systems, the ultrasound
transducer is typically localized with respect to the treatment
isocenter, and its 3D position is measured. By calibrating the
system, the location and orientation of the ultrasound images
can then be referenced to room coordinate system, and hence
the location of the prostate can be localized in 3D and refer-
enced to the treatment isocenter.250 In these prostate localiza-
tion systems, the transabdominal ultrasound transducer is
held by the operator, and the transducer’s position and orien-
tation is tracked using an external tracking device, e.g., ar-
ticulated arms,251 infrared tracking,252 camera-based optical
tracking with 3D ultrasound imaging, and real-time ultra-
sound monitoring.253 A specialty 3D ultrasound imaging sys-
tem is available for breast and prostate radiotherapy Reso-
nant Medical, Montreal, Canada.
XIV.A.2. Transrectal US „TRUS…-guided permanent
implant prostate brachytherapy
Prostate brachytherapy is a form of radiation therapy in
which about 80 to 100 radioactive seeds e.g., 125I or 103Pd
are placed permanently into the prostate.254,255 Because the
control rates of prostate cancer appear to be dose dependent,
it is theorized that the higher doses produced by brachy-
therapy will yield higher control rates than external-beam
radiation without a rise in complications. In the past decade,
removable implant techniques have been developed and used
in some institutions. In either technique, in order to deliver a
high conformal dose safely to the prostate, radioactive
sources must be positioned accurately within the gland,
which can be accomplished using ultrasound guidance.256,257
Transrectal US guidance TRUS: Real-time TRUS guid-
ance for prostate brachytherapy was introduced by Holm in
1981 Ref. 258 and refined by Blasko and Grimm, increas-
ing its popularity.259,260 Currently, the most common ap-
proach makes use of a TRUS-based preimplantation dose
plan preplan to determine the total activity and distribution
of the radioactive seeds in the prostate. At a later outpatient
visit, the seeds are implanted under general or spinal anes-
thesia using TRUS guidance, while the patient is placed in
the “same” lithotomy position as the preplan. At a later sepa-
rate patient visit, the actual seed locations are determined
with CT or fluoroscopy and a postimplantation plan post-
Medical Physics, Vol. 36, No. 2, February 2009plan is generated.261 If errors are detected e.g., “cold spot”,
then additional seeds may be added, but seeds cannot be
removed.
Typically, a biplane TRUS transducer is used, which con-
tains a side-firing linear transducer array and a curved array
positioned near the tip producing an axial view perpendicular
to the linear array. The probe is covered with a water-filled
condom to allow good contact with the rectal wall, inserted
into the rectum and attached to the brachytherapy assembly,
which includes a needle guidance template and a manual
stepper. The template guides the needles into the prostate in
rectilinear and parallel trajectories, limited by the pattern of
holes and positioning of the template.
Dose planning: For preimplant dose planning preplan,
the US transducer is typically withdrawn in 5 mm steps,
while a 2D image is acquired at each step, resulting in about
7 to 10 2D transverse images. Typically, the margins of the
prostate in the 2D images are contoured manually with a
mouse and used in the treatment optimization software,
which yields source positions for target coverage.256,260
Implantation: During the implantation phase, the patient is
positioned in a similar orientation to the preplanning posi-
tion. Once the TRUS transducer is in position, needles are
inserted under TRUS guidance. Since the needles are often
deflected during insertion, 2D TRUS visualization helps to
detect the deflection. If the deflection is significant, then the
needle is reinserted.
Recent advances: 2D TRUS-guided prostate planning and
implantation has been extended to include significant ad-
vances such as 3D ultrasound262,263 robotic aids,263–266 dy-
namic reoptimization, needle tracking,267,268 and seed seg-
mentation from ultrasound images.269 This type of approach
permits planning and implantation at the same session,
thereby avoiding problems of repositioning, prostate motion,
and prostate size/contour changes between the preplan and
the implantation. These improvements in the procedure have
made use of advances in ultrasound imaging along 2 fronts:
3D prostate ultrasound imaging, and semiautomated prostate
contouring in ultrasound images.
XIV.A.3. 3D TRUS imaging
3D TRUS systems270 can make use of a side-firing linear
array transducer, which is coupled to a rotational motorized
mover.
271,272 The mover rotates the transducer around its
long axis over a rotation angle of about 100° to generate a
sequence of 2D images arranged in the shape of a
fan.262,273,274 As the transducer is rotated, 2D US images
from the US machine are digitized at typically 0.7° intervals
at 30 or 15 Hz by a frame grabber and stored in the com-
puter. The 2D images are reconstructed into a 3D image
while the 2D images are being acquired, allowing immediate
viewing of the 3D image.271 Figure 6 shows an example of
the quality of 3D TRUS prostate images that can be
achieved.
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Since outlining the prostate margins manually is time-
consuming and tedious, a semi- or fully automated prostate
segmentation technique is required that is accurate, repro-
ducible, and fast.275 Because 3D US images suffer from
shadowing, speckle, and poor contrast, fully automated seg-
mentation procedures result, at times, in unacceptable errors.
Over the past decade, many investigators have developed
automated and semiautomated segmentation approaches, and
some are now available in clinical TRUS-based prostate
brachytherapy systems.
In one approach, the prostate is segmented in a series of
cross-sectional 2D image slices obtained from the 3D TRUS
image, and the resulting set of boundaries is assembled into a
single 3D prostate boundary.276,277 The method consists of
three steps: i The operator manually initializes the algo-
rithm by selecting four or more points on the prostate bound-
ary in one central prostate 2D slice. A curve passing through
these points is then calculated and is used as the initial esti-
mate of the prostate boundary. ii The curve is deformed
using a discrete dynamic contour algorithm until it reaches
equilibrium. If required, the curve can be edited by manually
repositioning selected vertices. iii The 2D segmented pros-
tate boundary in one slice is extended to 3D by propagating
the contour to an adjacent slice and repeating the deforma-
tion process. This is accomplished by slicing the prostate in
radial slices separated by a constant angle e.g., 3° intersect-
ing along an axis approximately in the center of the
277
FIG. 6. Three-dimensional prostate images obtained with a TRUS ultra-
sound transducer coupled to a mechanical rotational scanning mechanism.
a 3D TRUS image with three orthogonal views; b the 3D TRUS image of
the prostate has been segmented; c 3D TRUS image of a brachytherapy
patient obtained after the procedure. The image has been sliced to reveal
rows of brachytherapy seeds arrow. d The same image as in c but sliced
in the coronal plane not available using conventional TRUS imaging re-
vealing three rows of brachytherapy seeds arrow. Adapted from Ref. 272,
Fenster et al.prostate. The accuracy of the prostate segmentation algo-
Medical Physics, Vol. 36, No. 2, February 2009rithm has been tested by comparing its results with manual
outlining and shown to have a mean error of −1.7% with a
standard deviation of 3.1%.277,278 Segmentation of the pros-
tate requires about 8 s when implemented on a 2 GHz PC.
XV. SUMMARY
This subject area is clearly a large one to cover in a short
review. The activity and contributions by the AAPM and
medical physicists have not been at the same level as in
imaging and treatment with ionizing radiation, where most
medical physicists received their training. However, as illus-
trated, the contributions have been extensive in this major
imaging and therapeutic modality.
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